Literature DB >> 32388327

Editorial: Herd mentality, herds of migrants/people, and COVID-19 in India.

Awadhesh Kumar Singh1, Anoop Misra2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32388327      PMCID: PMC7198411          DOI: 10.1016/j.dsx.2020.05.004

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


× No keyword cloud information.
In this era of COVID-19 pandemic, even scientifically tempered physicians are prone to believe sensationalism, rumors and anecdotal data, more so when it is in the form of repetitive barrage on social media. Story of chloroquine (CQ) and hydroxychloroquine (HCQ) is a prime example of widespread ‘herd mentality’. Since doctors (and even patients) are well conversant with these drugs in India, having used it in tropical diseases like malaria, amoebiasis etc., it was ‘easy for them to believe’ regarding its ‘magical effects’. When first reports of ‘efficacy’ of these compounds came in, we were inundated with the queries mostly for the prophylaxis rather than treatment of COVID-19, despite no evidence of its benefit. At this time, even apex scientific research agency of India, Indian Council of Medical Research (ICMR), hurriedly issued guideline for prophylaxis of COVID-19, thus clearing use of HCQ in high risk contacts [1]. Interestingly, no other health agency globally has given such directive till date. After ICMR directive for prophylaxis of COVID-19 for Indians, there were long waiting lines in front of medical shops for buying these drugs, even without authorized prescription. This ‘herd mentality’ of taking HCQ as ‘prophylactic drug’ was seen far and wide amongst physician community as well, although most of them were not in contact with any COVID-19 patient. As a result, patients who genuinely needed HCQ (e.g. for rheumatoid arthritis) could not get it [2]. Concerns regarding lack of evidence of CQ or HCQ in human trials for mass prophylaxis for COVID 19 was expressed by only a few [3,4]. Meanwhile, herd mentality continues unabated in India; social media is still dominated by how to take these drugs and inquiry about their doses. Interestingly, while people are still deeply engaged in such conversations, little attention have been given to the damaging ‘herd behavior’ e.g. not following balanced diets, exercise and social distancing. Mass gatherings continued during lockdown (e.g. herds of migrants returning to their native places from cities, herd of people gathering in religious assemblies, in meetings of ‘super spreader’ preachers [5] and clustering at marriage ceremonies) despite major spread of COVID-19 have been witnessed in other countries following such events. In India, messages to obviate such ‘herd mentality’ (blindly following untrusted advice regarding prophylaxis and treatment) and ‘herd behavior’ (e.g. joining celebrities, preachers etc., in religious and social events) has to be strongly communicated to all segment of society, including physicians.

Declaration of competing interest

Nothing to declare.
  3 in total

1.  Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.

Authors:  Deepak Jakhar; Ishmeet Kaur
Journal:  Nat Med       Date:  2020-05       Impact factor: 53.440

2.  A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).

Authors:  Sanket Shah; Saibal Das; Avinash Jain; Durga Prasanna Misra; Vir Singh Negi
Journal:  Int J Rheum Dis       Date:  2020-04-27       Impact factor: 2.454

3.  Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.

Authors:  Awadhesh Kumar Singh; Akriti Singh; Altamash Shaikh; Ritu Singh; Anoop Misra
Journal:  Diabetes Metab Syndr       Date:  2020-03-26
  3 in total
  2 in total

1.  The Impact of COVID-19 Pandemic on Psychiatric Emergencies in Two Different Settings: Emergency Room and Community Mental Health Service.

Authors:  Rosaria Di Lorenzo; Margherita Pinelli; Davide Bertani; Anna Cutino; Diego Dragone; Claudia Elia; Riccardo Farina; Gianluca Fiore; Filippa Luisi; Sofia Panico; Laura Valeo; Sergio Rovesti; Paola Ferri
Journal:  Front Psychiatry       Date:  2022-05-26       Impact factor: 5.435

2.  Public Perception About Pandemic Situation and Preparedness Towards a Probable Lockdown in an Affected Indian State Amidst the Second Wave of the Covid-19 Pandemic.

Authors:  Shibaji Gupta; Abhishek De; Rudradeep Banerjee; Sharmistha Sinha Gupta; Arup Chakraborty
Journal:  Disaster Med Public Health Prep       Date:  2022-08-05       Impact factor: 5.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.